Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Gimme Care vs Levers Health

Gimme Care
Graded #23

Higher grade

vs+31.299999999999997
Levers Health
Graded #469

Lower grade

The verdict

Gimme Care takes it — 84.6/100 to 53.3/100.

Gimme Care grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Mid-value both-molecule pricing ($130/$163), verified, and nationwide.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueGimme Care +55
89
34
Dose & formulationGimme Care +26
80
54
Clinical oversightGimme Care +13
84
71
Labs & monitoringGimme Care +29
82
53
FulfillmentGimme Care +25
87
62
Contract termsGimme Care +30
85
55
Gimme Care · left barLevers Health · right bar

The numbers

MetricGimme CareLevers Health
WeighScore84.6/10053.3/100
GradeBC
Scorecard rank#23#469
Semaglutide$130/mo$247/mo (1.25 mg dose, compounded)
Tirzepatide$163/mo$296/mo (5 mg dose, compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Gimme Care

Graded #23 · B

Strengths

  • $130 sema / $163 tirz
  • All 50 states, LegitScript-verified
  • Both molecules

Where it loses points

  • Not the cheapest tier
  • Injection-only
  • Monitoring detail limited
Levers Health

Graded #469 · C

Strengths

  • Named LLC entity
  • Microdose GLP-1 option marketed for longevity
  • Both semaglutide and tirzepatide available

Where it loses points

  • No LegitScript or PCAB accreditation
  • No physical address disclosed
  • State availability not disclosed
  • FAQ and terms pages return 404
  • Above-average pricing ($247-$396/mo); tirzepatide any-dose plan is $396/mo (only the up-to-5mg low-dose plan is $296)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard